Aurobindo Pharma’s arm incorporates wholly owned subsidiary in Netherlands

28 May 2025 Evaluate

Aurobindo Pharma’s wholly owned subsidiary (WOS) -- Curateq Biologics has incorporated a new wholly owned subsidiary in the Netherlands by the name of CuraTeQ Biologics B.V. The newly incorporated entity belongs to biopharma products industry. The object of incorporation of this WOS is to expand the biopharma products business in Europe.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1191.15 8.65 (0.73%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×